The Valley Desk

NCT02360215 · Interventional trial

Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases

Overall registry status Completed

Phase 3

Conditions Cognitive Impairment, Metastatic Malignant Neoplasm in the Brain, Solid Neoplasm

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov